Results 231 to 240 of about 55,025 (289)

Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response. [PDF]

PLoS Biol
Chatrin C, Zhu K, Simmons MDR, Maginn L, Schützenhofer K, Lu Y, Đukić N, Wijngaarden S, Kloet MS, Kliza KW, Heden van Noort GJV, Filippov DV, Ahel D, Smith R, Ahel I.   +14 more
europepmc   +1 more source

PARP1 and PARP2 are dispensable for DNA repair by microhomology-mediated end-joining at double-ended DSBs. [PDF]

Nucleic Acids Res
Ortega R, Taylor ER, Whitehead SM, Danhorn T, Bitler BG, Arnoult N.   +5 more
europepmc   +1 more source

Phase separation of β-catenin assembles active loop hubs in colorectal cancer. [PDF]

Genome Biol
Yang J, Sun J, Zhang H, Yu Y, Chen F, Mo J, Luo S, Xu Y, Zhong L, Tan D, Lin Y, Liao Y, Zhang Y, Zhang J, Chen W, Huang X, Peng Y, Gao H, Wang H, Gong Q, Wang J.   +20 more
europepmc   +1 more source

Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas [PDF]

, 2018
Bailey, Matthew H, Ding, Li, et al,
core   +1 more source

Synergistic Cellular Toxicity from Inhibition of Poly(ADP-ribose) Glycohydrolase (PARG) and Ubiquitin-Specific Protease 1 (USP1). [PDF]

Toxics
Leonard SM, Pearson CR, Roos WP, Sobol RW.   +3 more
europepmc   +1 more source

From Coffee Alkaloid to Ovarian Targets: An Integrated Computational Framework for Trigonelline in Ovarian Aging. [PDF]

Food Sci Nutr
Yong WS, Han Y, Shen Y, Sun N, Zhang Q.
europepmc   +1 more source

<i>Lavandula stoechas</i> Ethanol Extracts Induce Apoptosis in Breast, Bladder, and Glioblastoma Cancer Cells. [PDF]

Pharmaceutics
Nalkiran I, Sevim Nalkiran H.
europepmc   +1 more source

PARPs and PARP inhibitors: molecular mechanisms and clinical applications. [PDF]

Mol Biomed
Wang F, Guo Z, Carr MJ, Shi W.
europepmc   +1 more source